Novavax is an anti-COVID vaccine that has been submitted to the FDA for approval. Developed by a Maryland biotech company, Novavax is already in use in 170 countries, including the UK and here in Australia.
It is a traditional protein vaccine, similar to today’s flu shots, as opposed to the new-style mRNA vaccines developed by Moderna and Pfizer. Novavax is derived from moth cells. The company says it is showing 90% effectiveness.